Literature DB >> 25376558

Attitude of epilepsy patients and their attendants for participating in research on status epilepticus.

Usha Kant Misra1, Gourav Goyal, Abhijeet Kumar Kohat, Ajit Kumar, Jayantee Kalita.   

Abstract

To evaluate the reason joining in status epilepticus (SE) trial by epilepsy patients and attendants and their preferences for types of trials and consent. The participants were interviewed after giving a SE case summary. Their demographic details, reason of consenting or non-consenting and preference of trials and type of consent were noted. The responses of the patients and attendants were compared. 77 subjects participated and 47 (61 %) were willing to participate in the trial mainly due to self-interest (treatment by specialist, best treatment and treatment availability only by trial). The reasons for unwilling were apprehension and lack of will. The participants preferred a head-to-head trial over a placebo-controlled (21 vs. 3), proxy consent rather than waived consent (16 vs. 6) and preconsent (16 vs. 3). These responses were not different between patients and attendants. 61 % subjects were willing to participate in SE trial especially in head-to-head trial with proxy consent.

Entities:  

Mesh:

Year:  2014        PMID: 25376558     DOI: 10.1007/s10072-014-1933-z

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  5 in total

Review 1.  The problem of informed consent in emergency medicine research.

Authors:  B A Foëx
Journal:  Emerg Med J       Date:  2001-05       Impact factor: 2.740

2.  What makes placebo-controlled trials unethical?

Authors:  Franklin G Miller; Howard Brody
Journal:  Am J Bioeth       Date:  2002       Impact factor: 11.229

3.  Ethics of randomized clinical trials.

Authors:  E J Emanuel; W B Patterson
Journal:  J Clin Oncol       Date:  1998-01       Impact factor: 44.544

4.  Placebo orthodoxy in clinical research. I: Empirical and methodological myths.

Authors:  B Freedman; C Weijer; K C Glass
Journal:  J Law Med Ethics       Date:  1996       Impact factor: 1.718

5.  Attitudes toward clinical trials among patients and the public.

Authors:  B R Cassileth; E J Lusk; D S Miller; S Hurwitz
Journal:  JAMA       Date:  1982-08-27       Impact factor: 56.272

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.